Sierra Oncology Inc (OQ:SRRA)

Business Focus: Bio Therapeutic Drugs

Recent Price for SRRA
USD 1.568 +0.158 (+11.206%)
NASDAQ Delayed 15 minutes
09:58 EST
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
1.600 8.240 N/A 600,559 78.17
1-Day Low 52-Week Low Yield Avg. Volume  
1.500 1.310 0.0% 281,253  

Latest 10 SEC filings (by transaction date) for SRRA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 16/17 Feb 14/17 Topper James N Indirect Ownership Common Stock P - Open market or private purchase 5,925,926 $1.35
Jan 4/17 Jan 4/17 Kowalski Mark Direct Ownership No securities beneficially held Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jan 4/17 Jan 3/17 Kowalski Mark Direct Ownership Stock Option (right to buy Class A Common Stock) A - Grant, award or other under Rule 16b-3(d) 300,000  
Nov 10/16 Nov 8/16 Parfet Donald R Direct Ownership Common Stock J - Other transaction 2,403  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction -4,806  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction 1,423  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction 3,383  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction 6,767  
Oct 4/16 Sep 30/16 Jagpal Sukhi Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 168,000  
Oct 4/16 Sep 30/16 Klencke Barbara Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 456,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for SRRA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 16/17 Feb 14/17 Topper James N Indirect Ownership Common Stock P - Open market or private purchase 5,925,926 $1.35
Jan 4/17 Jan 3/17 Kowalski Mark Direct Ownership Stock Option (right to buy Class A Common Stock) A - Grant, award or other under Rule 16b-3(d) 300,000  
Jan 4/17 Jan 4/17 Kowalski Mark Direct Ownership No securities beneficially held Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 10/16 Nov 8/16 Parfet Donald R Direct Ownership Common Stock J - Other transaction 2,403  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction -4,806  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction 1,423  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction 3,383  
Nov 10/16 Nov 8/16 Parfet Donald R Indirect Ownership Common Stock J - Other transaction 6,767  
Oct 4/16 Sep 30/16 Jagpal Sukhi Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 168,000  
Oct 4/16 Sep 30/16 Klencke Barbara Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 456,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $SRRA

StockTwits